Previous 10 | Next 10 |
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors PR Newswire - Former CEO Steve Rusckowski Remains as Chairman Through March 2023 SECAUCUS, N.J. , Nov. 1, 2022 /PRNewswire/ -- Q...
SAINT LOUIS UNIVERSITY TEAMS UP WITH QUEST DIAGNOSTICS ON ACCELERATED BACHELOR OF SCIENCE IN MEDICAL LABORATORY SCIENCE PR Newswire Cutting-Edge Program to Help Fill the Dire Shortage of Behind-the-Scenes Heroes Who Perform Laboratory Testing that Informs Patient Dia...
Bread of Life, Inc. teams up with the Quest Diagnostics Foundation and local community partners to improve access to healthcare and create job opportunities for underserved communities PR Newswire Healthy Houston Collective includes a multipronged approach to addressin...
Sesame Workshop and Quest Diagnostics Team Up to Address Health and Well-Being Inequities with Resources Connecting Parents and Healthcare Providers PR Newswire NEW YORK , Oct. 27, 2022 /PRNewswire/ -- Sesame Workshop, the nonprofit educational organizati...
Shares of Quest Diagnostics (NYSE: DGX) climbed 6.3% on Thursday after the medical testing giant boosted its full-year sales and profit forecast. Quest's revenue decreased by 10% year over year to $2.5 billion in the third quarter. The decline was driven by a 55% drop in the...
Quest Diagnostics Incorporated (DGX) Q3 2022 Earnings Conference Call October 20, 2022 08:30 AM ET Company Participants Shawn Bevec - VP of IR Steve Rusckowski - Chairman, President & Chief Executive Officer Jim Davis - CEO Sam Samad - CFO Conferenc...
Quest Diagnostics ( NYSE: DGX ) is trading 5.6% higher after it raised its guidance and beat revenue, profit estimates as its business rebounding in August and September from the softer volume trends seen earlier in the year. The company now expects 2022 ...
Quest Diagnostics ( NYSE: DGX ) is scheduled to announce Q3 earnings results on Thursday, October 20th, before market open. The consensus EPS Estimate is $2.18 (-44.9% Y/Y) and the consensus Revenue Estimate is $2.34B (-15.5% Y/Y). Over the last 2 years, DGX has beat...
Healthcare artificial intelligence company Decode Health will partner with Quest Diagnostics ( NYSE: DGX ) on using biomarker-based data to cut the time and cost of developing novel diagnostic tests and identifying new drug targets . Both companies have developed a pla...
Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development PR Newswire Features Nationally Scaled RNA Sequencing and Specimen Collection for Multiple Sclerosis and Non-Alcoholic Fatty Liver Disease with Plans to Ex...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...